Samsung Biologics

Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment

Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry Advances from 'Low Risk' to 'Negligible Risk,' the…